Drugs / [2-13C] uracil
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01074710 | Feb → May 2010 | gastroparesis | Otsuka Pharmaceutical Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [2-13C] uracil | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01074710 ↗ |
| Route | Oral | “single oral dose” NCT01074710 ↗ |